Centessa Pharmaceuticals Plc ADR
(CNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -131,369 | -76,478 | -26,135 | -235,757 | -124,428 |
| Depreciation Amortization | 1,556 | 1,048 | -1,553 | 942 | 712 |
| Income taxes - deferred | 2,276 | 2,021 | 995 | 2,653 | 2,255 |
| Accounts payable and accrued liabilities | 1,362 | -1,918 | -2,095 | -4,585 | -4,728 |
| Other Working Capital | -31,250 | -19,986 | -38,436 | 22,164 | -3,012 |
| Other Operating Activity | 19,415 | 15,615 | 9,978 | 72,528 | 29,946 |
| Operating Cash Flow | $-138,010 | $-79,698 | $-57,246 | $-142,055 | $-99,255 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -200,037 | -262,216 | -222,388 | 31,301 | 6,301 |
| PPE Investments | -360 | -126 | N/A | -34 | -34 |
| Investing Cash Flow | $-200,397 | $-262,342 | $-222,388 | $31,267 | $6,267 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 109,335 | N/A |
| Common Stock Issued | 13,139 | 9,577 | 7,872 | 370,832 | 365,520 |
| Other Financing Activity | -5,011 | -4,886 | -4,786 | -115,415 | -3,731 |
| Financing Cash Flow | $8,128 | $4,691 | $3,086 | $364,752 | $361,789 |
| Exchange Rate Effect | -2,131 | -1,630 | -1,517 | 1,227 | -1,805 |
| Beginning Cash Position | 383,221 | 383,221 | 383,221 | 128,030 | 128,030 |
| End Cash Position | 50,811 | 44,242 | 105,156 | 383,221 | 395,026 |
| Net Cash Flow | $-332,410 | $-338,979 | $-278,065 | $255,191 | $266,996 |
| Free Cash Flow | |||||
| Operating Cash Flow | -138,010 | -79,698 | -57,246 | -142,055 | -99,255 |
| Capital Expenditure | -360 | -126 | N/A | -34 | -34 |
| Free Cash Flow | -138,370 | -79,824 | -57,246 | -142,089 | -99,289 |